MyFinsight
Home
Blog
About
Proceeds from the
exercise of stock options
$158K
(-34.17%↓ Y/Y)
Net cash provided by
financing activities
$158K
(-95.80%↓ Y/Y)
Net change in cash
-$1,576K
(-13033.33%↓ Y/Y)
Canceled cashflow
$158K
Accrued expenses
$5,729K
(11.52%↑ Y/Y)
Share-based compensation
$1,437K
(-45.96%↓ Y/Y)
Inventory
-$1,136K
(28.06%↑ Y/Y)
Amortization of acquired
intangible assets
$969K
(-54.49%↓ Y/Y)
Prepaid expenses and
other current assets
-$728K
(0.68%↑ Y/Y)
Amortization of debt discount
$99K
(-56.00%↓ Y/Y)
Accrued interest
$26K
(116.67%↑ Y/Y)
Amortization of operating
lease right-of-use...
$23K
(-46.51%↓ Y/Y)
Net cash provided by
(used in) operating...
-$1,734K
(54.05%↑ Y/Y)
Canceled cashflow
$10,147K
Accounts receivable
$11,243K
(117.59%↑ Y/Y)
Net loss
-$312K
(96.04%↑ Y/Y)
Accounts payable
-$153K
(95.36%↑ Y/Y)
Income tax payable
-$70K
(-736.36%↓ Y/Y)
Due to related party
-$67K
(-121.47%↓ Y/Y)
Lease liabilities
-$25K
(30.56%↑ Y/Y)
Bad debt expense
(recovery)
-$11K
(95.53%↑ Y/Y)
Back
Back
Cash Flow
Journey Medical Corp (DERM)
Journey Medical Corp (DERM)
source: myfinsight.com